NDARECTALSUPPOSITORY
Approved
Apr 1980
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
5/8 — Partial
ACETAMINOPHEN (acetaminophen) by Gland Pharma is 12. Approved for pain, postoperative pain, osteoarthritis and 2 more indications. First approved in 1980.
Drug data last refreshed 20h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Acetaminophen is a non-opioid analgesic and antipyretic agent indicated for pain management and fever reduction across multiple conditions including postoperative pain, osteoarthritis, and chronic low back pain. The precise mechanism remains incompletely understood but is thought to involve central nervous system actions. It is available as a rectal suppository formulation, offering an alternative route of administration to oral preparations.
LOE Approaching
LOE-approaching lifecycle indicates declining market exclusivity and team contraction; expect consolidation toward generic manufacturing and cost-optimization roles.
Mechanism of Action
12.1 Mechanism of Action The precise mechanism of the analgesic and antipyretic properties of acetaminophen is not established but is thought to primarily involve central actions. 12.2 Pharmacodynamics Acetaminophen has been shown to have analgesic and antipyretic activities in animal and human…
Worked on ACETAMINOPHEN at Gland Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.